Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127616371 | 12761637 | 1 | I | 20160824 | 20160908 | 20160920 | 20160920 | EXP | GB-MHRA-ADR 23631629 | GB-AXELLIA-000982 | XELLIA PHARMACEUTICALS | 1.00 | YR | F | Y | 0.00000 | 20160920 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127616371 | 12761637 | 1 | PS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous drip | 495 | MG | Y | 206243 | 165 | MG | TID | |||||
| 127616371 | 12761637 | 2 | C | PHENOBARBITAL. | PHENOBARBITAL | 1 | Oral | 50MG/5ML | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127616371 | 12761637 | 1 | Central nervous system infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127616371 | 12761637 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127616371 | 12761637 | Hypersensitivity | |
| 127616371 | 12761637 | Red man syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127616371 | 12761637 | 1 | 20160824 | 20160824 | 0 |